Draft Genome Sequences of Clinical Isolates of Serotype 6E Streptococcus pneumoniae from Five Asian Countries-Reference-Cited by-同舟云学术

Draft Genome Sequences of Clinical Isolates of Serotype 6E Streptococcus pneumoniae from Five Asian Countries

Published:2017-03-09 Issue:10 Volume:5 Page:
ISSN:2169-8287
Container-title:Genome Announcements
language:en
Short-container-title:Genome Announc

Author:

Park In Ho¹,Baek Jin Yang²,Song Jae-Hoon²³,Ko Kwan Soo²⁴,Kim Kyung-Hyo¹⁵

Affiliation:

1. Center for Vaccine Evaluation and Study, Medical Research Institute, Ewha Womans University, Seoul, Republic of Korea

2. Asia Pacific Foundation for Infectious Diseases (APFID), Seoul, Republic of Korea

3. Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

4. Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea

5. Department of Pediatrics, School of Medicine, Ewha Womans University, Seoul, Republic of Korea

Abstract

ABSTRACT Although serotype 6E Streptococcus pneumoniae consistently expresses capsules of either vaccine-serotype 6A or 6B, certain genetic variants of serotype 6E may evade vaccine induced immunity. Thus, draft genome sequences from five clinical isolates of serotype 6E from each of five different Asian countries have been generated to provide insight into the genomic diversity in serotype 6E strains.

Funder

National Research Foundation of Korea

Korea Health and Welfare Information Service

Ewha Womans University

Publisher

American Society for Microbiology

Subject

Genetics,Molecular Biology

Link

https://journals.asm.org/doi/pdf/10.1128/genomeA.01728-16

Reference14 articles.

1. Predominance of ST320 among Streptococcus pneumoniae serotype 19A isolates from 10 Asian countries

2. Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study

3. Incidence of Pneumococcal Disease Due to Non–Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004

4. Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine Coverage

5. Impact of a single dose of the 7-valent pneumococcal conjugate vaccine on colonization